GlassScriptPhysician profile
Kay R Hatton
NPI 1952364663
$1,882.18
in general payments reported to CMS, 2019-2025
13 companies · $306 in 2025
The $306 reported for 2025 was more than what 96% of Perinatal (Nurse Practitioner) providers received nationally (typical 2025 total: $29.14).
See the full distribution for Perinatal (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $203 · 2023: $332 · 2024: $503 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $313.04 | 2021-2024 | Airsupra |
| Abbvie INC. | $311.33 | 2021-2023 | |
| Abbott Laboratories | $256.36 | 2021-2025 | Freestyle Libre 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.08 | 2021 | |
| Dexcom, INC. | $143.39 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $122.79 | 2024 | Wegovy |
| Phathom Pharmaceuticals, INC. | $122.79 | 2024 | Voquezna |
| Edwards Lifesciences Corporation | $122.18 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Alnylam Pharmaceuticals INC. | $106.10 | 2022 | |
| Medtronic, INC. | $87.82 | 2023 | Interstim |
| Genzyme Corporation | $82.32 | 2021 | |
| Stryker Corporation | $34.22 | 2024 | Scopis Ent |
| Smith+Nephew, INC. | $21.76 | 2025 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Hatton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.